A detailed history of Pro Vise Management Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 4,610 shares of ABT stock, worth $524,756. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,610
Previous 4,649 0.84%
Holding current value
$524,756
Previous $483,000 8.7%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $3,902 - $4,607
-39 Reduced 0.84%
4,610 $525,000
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $100 - $112
1 Added 0.02%
4,649 $483,000
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $34,608 - $38,223
-316 Reduced 6.37%
4,648 $528,000
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $90 - $110
1 Added 0.02%
4,964 $546,000
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $8,024 - $9,628
-84 Reduced 1.66%
4,963 $480,000
Q2 2023

Aug 24, 2023

SELL
$100.78 - $112.29 $1,914 - $2,133
-19 Reduced 0.38%
5,047 $550,000
Q1 2023

May 05, 2023

SELL
$96.86 - $114.01 $10,267 - $12,085
-106 Reduced 2.05%
5,066 $512,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $10,931 - $12,824
-115 Reduced 2.18%
5,172 $567,000
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $2,128 - $2,464
22 Added 0.42%
5,287 $512,000
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $28,375 - $34,296
-278 Reduced 5.02%
5,265 $572,000
Q1 2022

Apr 27, 2022

SELL
$114.02 - $139.04 $82,436 - $100,525
-723 Reduced 11.54%
5,543 $656,000
Q4 2021

Jan 18, 2022

SELL
$115.53 - $141.46 $19,640 - $24,048
-170 Reduced 2.64%
6,266 $882,000
Q3 2021

Oct 20, 2021

SELL
$116.66 - $129.06 $54,246 - $60,012
-465 Reduced 6.74%
6,436 $760,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $43,902 - $51,679
-415 Reduced 5.67%
6,901 $800,000
Q1 2021

Apr 22, 2021

SELL
$108.84 - $128.23 $5,442 - $6,411
-50 Reduced 0.68%
7,316 $877,000
Q4 2020

Jan 19, 2021

BUY
$105.0 - $114.42 $42,735 - $46,568
407 Added 5.85%
7,366 $807,000
Q3 2020

Oct 26, 2020

SELL
$91.64 - $111.29 $15,853 - $19,253
-173 Reduced 2.43%
6,959 $757,000
Q2 2020

Aug 07, 2020

SELL
$76.57 - $98.0 $21,822 - $27,930
-285 Reduced 3.84%
7,132 $652,000
Q1 2020

May 07, 2020

SELL
$62.82 - $91.86 $18,846 - $27,558
-300 Reduced 3.89%
7,417 $585,000
Q4 2019

Feb 11, 2020

SELL
$78.51 - $87.4 $1,648 - $1,835
-21 Reduced 0.27%
7,717 $670,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $371,553 - $402,879
-4,540 Reduced 36.98%
7,738 $647,000
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $583 - $680
-8 Reduced 0.07%
12,278 $1.03 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $209,188 - $252,909
-3,159 Reduced 20.45%
12,286 $982,000
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $23,208 - $26,291
-354 Reduced 2.24%
15,445 $1.12 Million
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $8,148 - $9,830
134 Added 0.86%
15,799 $1.16 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $185,663 - $204,916
-3,225 Reduced 17.07%
15,665 $955,000
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $79,396 - $89,767
-1,411 Reduced 6.95%
18,890 $1.13 Million
Q4 2017

Feb 07, 2018

SELL
$53.68 - $57.47 $177,466 - $189,995
-3,306 Reduced 14.0%
20,301 $1.16 Million
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $1.13 Million - $1.27 Million
23,607
23,607 $1.26 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.